Health Encyclopedia

Prelu-2

Prelu-2 Uses, Dosage, Side Effects, and Warnings

Introduction to Prelu-2

Prelu-2 is an appetite suppressant medication used for weight loss in patients with obesity. It contains phendimetrazine, a stimulant drug that decreases appetite and promotes weight reduction when combined with a reduced-calorie diet and exercise routine.

Chemical Composition and Classification

The active ingredient in Prelu-2 is phendimetrazine tartrate, a morpholine analogue and prodrug of phenmetrazine. Phendimetrazine belongs to the morpholine chemical class of stimulant drugs.

Pharmacodynamics and Pharmacokinetics

Phendimetrazine acts as an appetite suppressant by stimulating the central nervous system. It is rapidly absorbed from the gastrointestinal tract with peak plasma levels occurring within 2-3 hours. The drug is metabolized in the liver and excreted by the kidneys, with an elimination half-life of about 12 hours.

Usage and Indications

Prelu-2 is indicated for the short-term management of obesity in adults and teenagers 17 years of age and older. It should be used in conjunction with a reduced-calorie diet and exercise program. The recommended dosage is one 105mg extended-release capsule taken once daily, 30-60 minutes before the morning meal.

Administration

Prelu-2 is administered orally as a 105mg extended-release capsule. It should be taken 30 to 60 minutes before the morning meal. Patients should swallow the capsule whole and not crush, chew, or divide it.

Drug Interactions

Prelu-2 may interact with other medications, including MAO inhibitors, sympathomimetics, and serotonergic drugs. Patients should inform their doctor of all medications they are taking before starting Prelu-2. Alcohol should be avoided while taking this medication.

Side Effects

Common side effects of Prelu-2 include dry mouth, constipation, insomnia, dizziness, and irritability. More severe side effects may include chest pain, rapid heartbeat, shortness of breath, and swelling of the ankles or feet. Long-term use may lead to tolerance, dependency, and withdrawal symptoms upon discontinuation.

Warnings and Precautions

Prelu-2 is contraindicated in patients with cardiovascular disease, hyperthyroidism, glaucoma, or a history of drug abuse. It should be used with caution in elderly patients and those with hypertension or diabetes. The safety of Prelu-2 in pregnant women and children under 17 has not been established.

Brand Names and Generic Alternatives

Prelu-2 is available under various brand names, including Adipost, Anorex-SR, Appecon, Bontril PDM, Bontril Slow Release, Melfiat, Obezine, Phendiet, Plegine, and Statobex. Generic phendimetrazine tartrate is also available.

Phendimetrazine is classified as a Schedule III controlled substance in the United States, indicating a moderate potential for abuse. It is approved by the FDA for short-term use in the management of obesity.

Patient Information

Patients should be advised to take Prelu-2 exactly as prescribed and not to exceed the recommended dosage. They should be counseled on the importance of adhering to a reduced-calorie diet and engaging in regular physical activity while taking the medication. Patients should be monitored regularly for efficacy, safety, and signs of abuse or dependence.

Diet and Exercise Recommendations

Prelu-2 should be used in combination with a reduced-calorie diet and exercise program. A daily deficit of 500-1000 calories is recommended for weight loss. Patients should aim for 150 minutes of moderate-intensity aerobic activity per week, along with resistance training to preserve lean body mass.

Comparison with Other Appetite Suppressants

Prelu-2 is one of several appetite suppressant medications available for the management of obesity. Other drugs in this class include phentermine, diethylpropion, and benzphetamine. The choice of medication depends on individual factors such as patient preference, side effect profile, and response to treatment.

FAQs

Prelu-2